Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-06
DOI
10.3389/fphar.2019.00588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic Suppression of the T-box Subfamily 2 (TBX2) in Human Non-Small Cell Lung Cancer
- (2019) Eliana Nehme et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Zebularine exerts its antiproliferative activity through S phase delay and cell death in human malignant mesothelioma cells
- (2018) Yukitoshi Takemura et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer
- (2018) Yunting Jian et al. CANCER LETTERS
- Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications
- (2018) Elisa Porcellini et al. CANCER LETTERS
- SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter
- (2018) Wendi Shuai et al. CANCER LETTERS
- Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors
- (2018) Eva Juengel et al. CANCER LETTERS
- Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer
- (2018) Eunsohl Lee et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation
- (2018) Yanquan Zhang et al. ONCOGENE
- SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression
- (2018) Nandaraj Taye et al. Oncotarget
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- Inhibition of HDAC7 reverses CNT2 repression in colorectal cancer by up-regulating histone acetylation state
- (2018) Chaonan Ye et al. BRITISH JOURNAL OF PHARMACOLOGY
- Zebularine significantly improves the preimplantation development of ovine somatic cell nuclear transfer embryos
- (2018) Hui Cao et al. REPRODUCTION FERTILITY AND DEVELOPMENT
- Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor CDKN1A in colon cancer cells
- (2018) Christian Gerecke et al. Oncotarget
- DNA methylation of CMTM3 , SSTR2 , and MDFI genes in colorectal cancer
- (2017) Jinyun Li et al. GENE
- Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines
- (2017) Elisabeth Enzenhofer et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance
- (2017) Wolfgang Gruber et al. INTERNATIONAL JOURNAL OF CANCER
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia
- (2017) Thomas Briot et al. International Journal of Nanomedicine
- Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy
- (2017) Yuichi Tambo et al. INVESTIGATIONAL NEW DRUGS
- The DNA-methyltransferase inhibitor 5-aza-2-deoxycytidine affects Humicola grisea enzyme activities and the glucose-mediated gene repression
- (2017) João Heitor C. Manfrão-Netto et al. JOURNAL OF BASIC MICROBIOLOGY
- Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway
- (2017) Huihan Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinoma
- (2017) Li R. Kong et al. Molecular Oncology
- Synergistic activity of everolimus and 5-aza-2′-deoxycytidine in medullary thyroid carcinoma cell lines
- (2017) Giovanni Vitale et al. Molecular Oncology
- Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner
- (2017) Vivek Kumar Mishra et al. NUCLEIC ACIDS RESEARCH
- Hypermethylation of NDN promotes cell proliferation by activating the Wnt signaling pathway in colorectal cancer
- (2017) Yu-Han Hu et al. Oncotarget
- Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition
- (2017) Xuexiao Wang et al. Oncotarget
- Resminostat induces changes in epithelial plasticity of hepatocellular carcinoma cells and sensitizes them to sorafenib-induced apoptosis
- (2017) Jitka Soukupova et al. Oncotarget
- 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression
- (2017) Adrien Morel et al. Oncotarget
- Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
- (2017) Krysta Mila Coyle et al. Biomed Research International
- 4SC-202 activates ASK1-dependent mitochondrial apoptosis pathway to inhibit hepatocellular carcinoma cells
- (2016) Meili Fu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
- (2016) Elena Ceccacci et al. BRITISH JOURNAL OF CANCER
- Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320–Mediated Suppression of the Androgen Receptor
- (2016) Shinya Sato et al. CANCER RESEARCH
- Chaetocin inhibits IBMX-induced melanogenesis in B16F10 mouse melanoma cells through activation of ERK
- (2016) Jung-Soo Bae et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study
- (2016) Michael Bitzer et al. JOURNAL OF HEPATOLOGY
- Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells
- (2016) Huang Zhijun et al. TUMOR BIOLOGY
- The anticancer effect of chaetocin is enhanced by inhibition of autophagy
- (2016) H-J Jung et al. Cell Death & Disease
- HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
- (2016) Elizabeth E. Hull et al. Biomed Research International
- Targeting histone methylation for colorectal cancer
- (2016) Tao Huang et al. Therapeutic Advances in Gastroenterology
- Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms
- (2015) Laura Novellasdemunt et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells
- (2015) Xianfang Liu et al. APOPTOSIS
- Effects of Decitabine on Invasion and Exosomal Expression of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells
- (2015) Shota Tanaka et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer
- (2015) N. Ichimura et al. Cancer Prevention Research
- Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy
- (2015) B. G. Cipolla et al. Cancer Prevention Research
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
- (2015) David Roulois et al. CELL
- Advances in the development of histone lysine demethylase inhibitors
- (2015) Tamara Maes et al. CURRENT OPINION IN PHARMACOLOGY
- Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma
- (2015) Christina Michailidi et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors
- (2015) Giovanna De Maglio et al. Future Oncology
- Chaetocin inhibits RANKL-induced osteoclast differentiation through reduction of Blimp1 in Raw264.7 cells
- (2015) Ning Zhao et al. LIFE SCIENCES
- Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor β
- (2015) Vikas Sharma et al. MOLECULAR CARCINOGENESIS
- Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression
- (2015) YACHAO ZHAO et al. Molecular Medicine Reports
- DAC can restore expression of NALP1 to suppress tumor growth in colon cancer
- (2015) C Chen et al. Cell Death & Disease
- The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells
- (2015) Y-S Lai et al. Blood Cancer Journal
- Vorinostat-An overview
- (2015) AdityaKumar Bubna INDIAN JOURNAL OF DERMATOLOGY
- DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation Status
- (2015) Kazuaki Nakamura et al. PLoS One
- 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft
- (2015) Alexandra Borodovsky et al. Oncotarget
- Epigenetic modifications in colorectal cancer: Molecular insights and therapeutic challenges
- (2014) Aristeidis G. Vaiopoulos et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma
- (2014) Tetsuhiro Chiba et al. INTERNATIONAL JOURNAL OF CANCER
- A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer
- (2014) Joshi J. Alumkal et al. INVESTIGATIONAL NEW DRUGS
- Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells
- (2014) Fengdong Cheng et al. MOLECULAR IMMUNOLOGY
- Chaetocin-induced ROS-mediated apoptosis involves ATM–YAP1 axis and JNK-dependent inhibition of glucose metabolism
- (2014) D Dixit et al. Cell Death & Disease
- Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by Controlling Ezh2 Expression and Epigenetic Reprogramming
- (2013) Neha Tiwari et al. CANCER CELL
- Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motilityin vitroand drives tumor formationin vivo
- (2013) Yuhki Yokoyama et al. CANCER SCIENCE
- First-in-human, Pharmacokinetic and Pharmacodynamic Phase I Study of Resminostat, an Oral Histone Deacetylase Inhibitor, in Patients with Advanced Solid Tumors
- (2013) A. T. Brunetto et al. CLINICAL CANCER RESEARCH
- Zebularine inhibits the growth of A549 lung cancer cells via cell cycle arrest and apoptosis
- (2013) Bo Ra You et al. MOLECULAR CARCINOGENESIS
- Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases
- (2013) Fanny L Cherblanc et al. Nature Chemical Biology
- HDAC Up-Regulation in Early Colon Field Carcinogenesis Is Involved in Cell Tumorigenicity through Regulation of Chromatin Structure
- (2013) Yolanda Stypula-Cyrus et al. PLoS One
- Kras Gene Mutation and RASSF1A, FHIT and MGMT Gene Promoter Hypermethylation: Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population
- (2013) Rupal Sinha et al. PLoS One
- Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress
- (2013) Pei-Ming Yang et al. Scientific Reports
- DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions
- (2012) Muktheshwar Gandesiri et al. APOPTOSIS
- Pan-Histone Deacetylase Inhibitor Panobinostat Sensitizes Gastric Cancer Cells to Anthracyclines via Induction of CITED2
- (2012) Ivonne Regel et al. GASTROENTEROLOGY
- Histone deacetylases and cancer
- (2012) Bruna Barneda-Zahonero et al. Molecular Oncology
- Histone methylation: a dynamic mark in health, disease and inheritance
- (2012) Eric L. Greer et al. NATURE REVIEWS GENETICS
- The Dual EGFR/HER2 Inhibitor Lapatinib Synergistically Enhances the Antitumor Activity of the Histone Deacetylase Inhibitor Panobinostat in Colorectal Cancer Models
- (2011) M. J. LaBonte et al. CANCER RESEARCH
- Epigenetic Regulation and Colorectal Cancer
- (2011) Nagahide Matsubara DISEASES OF THE COLON & RECTUM
- Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing ofCDX1andEPHBtumor suppressor genes in colorectal cancer
- (2011) Kerstin Rönsch et al. Epigenetics
- Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo
- (2011) Maria Graziella Catalano et al. INTERNATIONAL JOURNAL OF CANCER
- Histone Deacetylase Inhibitor Belinostat Represses Survivin Expression through Reactivation of Transforming Growth Factor β (TGFβ) Receptor II Leading to Cancer Cell Death
- (2011) Sanjib Chowdhury et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Colorectal Cancer Epigenetics: Complex Simplicity
- (2011) Manon van Engeland et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells
- (2011) John D. Clarke et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells
- (2010) Sonja Mandl-Weber et al. BRITISH JOURNAL OF HAEMATOLOGY
- Proteomic profiling of human colon cancer cells treated with the histone deacetylase inhibitor belinostat
- (2010) Hans Christian Beck et al. ELECTROPHORESIS
- Nonhistone protein acetylation as cancer therapy targets
- (2010) Brahma N Singh et al. Expert Review of Anticancer Therapy
- Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin
- (2010) Akiko Hayashi et al. INTERNATIONAL JOURNAL OF CANCER
- Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
- (2010) Jianqing Lin et al. PROSTATE
- DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
- (2009) Melissa J LaBonte et al. BMC Medical Genomics
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
- (2009) Peter Atadja CANCER LETTERS
- Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21
- (2009) Sarah Derks et al. CARCINOGENESIS
- The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines
- (2009) Michael B Prystowsky et al. JOURNAL OF PATHOLOGY
- Evolution of decitabine development
- (2008) Elias Jabbour et al. CANCER
- Sulforaphane Enhances the Therapeutic Potential of TRAIL in Prostate Cancer Orthotopic Model through Regulation of Apoptosis, Metastasis, and Angiogenesis
- (2008) S. Shankar et al. CLINICAL CANCER RESEARCH
- A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia
- (2008) Peter Gimsing et al. EUROPEAN JOURNAL OF HAEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More